Your browser doesn't support javascript.
loading
Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variants.
Flaum, Nicola; Crosbie, Emma J; Woodward, Emma R; Lalloo, Fiona; Gareth Evans, D.
Afiliação
  • Flaum N; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester Universi
  • Crosbie EJ; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, M13 9WL, UK. Electronic address:
  • Woodward ER; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester Universi
  • Lalloo F; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester Universi
  • Gareth Evans D; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, UK; Manchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester Universi
Eur J Cancer ; 124: 88-90, 2020 01.
Article em En | MEDLINE | ID: mdl-31760313

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína BRCA1 / Proteína BRCA2 Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteína BRCA1 / Proteína BRCA2 Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido